Literature DB >> 16228104

A list of device-specific thresholds for the clinical interpretation of peripheral x-ray absorptiometry examinations.

G M Blake1, D J Chinn, S A Steel, R Patel, E Panayiotou, J Thorpe, J N Fordham.   

Abstract

The UK National Osteoporosis Society (NOS) has recently issued new guidelines on the use of peripheral x-ray absorptiometry (pDXA) devices in managing osteoporosis. The NOS guidelines recommend a triage approach in which patients' bone mineral density (BMD) measurements are interpreted using upper and lower thresholds specific to each type of pDXA device. The thresholds are defined so that patients with osteoporosis at the hip or spine are identified with 90% sensitivity and 90% specificity. Patients with a pDXA result below the lower threshold are likely to have osteoporosis at the hip or spine, patients with a result above the upper threshold are unlikely to have osteoporosis, while those between the two thresholds require a hip and spine BMD examination for a definitive diagnosis. This report presents data from a multicenter study to establish the triage thresholds for a range of pDXA devices in use in the UK. The subjects were white female patients aged 55-70 years who met the normal referral criteria for a BMD examination. For each device, at least 70 women with osteoporosis at the hip or spine and 70 women without osteoporosis were enrolled. All women had hip and spine BMD measurements using axial DXA systems that were interpreted using the National Health and Nutrition Examination Survey (NHANES) reference range for the hip and the manufacturers' reference ranges for the spine. Data are presented for five different devices: the Osteometer DTX-200 (forearm BMD), the Schick AccuDEXA (hand BMD), the GE Lunar PIXI (heel BMD), the Alara MetriScan (hand BMD), and the Demetech Calscan (heel BMD). The clinical measurements were supplemented by theoretical modeling to estimate the age dependence of the triage thresholds and the effect of the correlation coefficient between pDXA and axial BMD on the percentage of women referred for an axial BMD examination. In summary, this study provides thresholds for implementing the new NOS guidelines for managing osteoporosis using pDXA devices. The figures reported apply to postmenopausal white women aged 55-70 years who meet the conventional criteria for a BMD examination. The results confirm that the thresholds are specific to each type of pDXA device and that the NOS triage algorithm requires 40% of women to have an axial DXA examination.

Entities:  

Mesh:

Year:  2005        PMID: 16228104     DOI: 10.1007/s00198-005-2018-x

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  28 in total

1.  Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the National Osteoporosis Risk Assessment.

Authors:  Paul D Miller; Ethel S Siris; Elizabeth Barrett-Connor; Kenneth G Faulkner; Lois E Wehren; Thomas A Abbott; Ya-Ting Chen; Marc L Berger; Arthur C Santora; Louis M Sherwood
Journal:  J Bone Miner Res       Date:  2002-12       Impact factor: 6.741

Review 2.  Treatment of postmenopausal osteoporosis.

Authors:  R Eastell
Journal:  N Engl J Med       Date:  1998-03-12       Impact factor: 91.245

Review 3.  Noninvasive assessment of bone mineral and structure: state of the art.

Authors:  H K Genant; K Engelke; T Fuerst; C C Glüer; S Grampp; S T Harris; M Jergas; T Lang; Y Lu; S Majumdar; A Mathur; M Takada
Journal:  J Bone Miner Res       Date:  1996-06       Impact factor: 6.741

4.  Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease.

Authors:  J A Kanis; P Delmas; P Burckhardt; C Cooper; D Torgerson
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

5.  Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.

Authors:  S T Harris; N B Watts; H K Genant; C D McKeever; T Hangartner; M Keller; C H Chesnut; J Brown; E F Eriksen; M S Hoseyni; D W Axelrod; P D Miller
Journal:  JAMA       Date:  1999-10-13       Impact factor: 56.272

6.  Classification of osteoporosis based on bone mineral densities.

Authors:  Y Lu; H K Genant; J Shepherd; S Zhao; A Mathur; T P Fuerst; S R Cummings
Journal:  J Bone Miner Res       Date:  2001-05       Impact factor: 6.741

7.  Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

Authors:  B Ettinger; D M Black; B H Mitlak; R K Knickerbocker; T Nickelsen; H K Genant; C Christiansen; P D Delmas; J R Zanchetta; J Stakkestad; C C Glüer; K Krueger; F J Cohen; S Eckert; K E Ensrud; L V Avioli; P Lips; S R Cummings
Journal:  JAMA       Date:  1999-08-18       Impact factor: 56.272

8.  Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.

Authors:  Charles H Chesnut; Arne Skag; Claus Christiansen; Robert Recker; Jacob A Stakkestad; Arne Hoiseth; Dieter Felsenberg; Hermann Huss; Jennifer Gilbride; Ralph C Schimmer; Pierre D Delmas
Journal:  J Bone Miner Res       Date:  2004-03-29       Impact factor: 6.741

9.  BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures.

Authors:  Katie L Stone; Dana G Seeley; Li-Yung Lui; Jane A Cauley; Kristine Ensrud; Warren S Browner; Michael C Nevitt; Steven R Cummings
Journal:  J Bone Miner Res       Date:  2003-11       Impact factor: 6.741

Review 10.  Peripheral or central densitometry: does it matter which technique we use?

Authors:  G M Blake; I Fogelman
Journal:  J Clin Densitom       Date:  2001       Impact factor: 2.963

View more
  20 in total

Review 1.  [Absorptiometry].

Authors:  S Prevrhal
Journal:  Radiologe       Date:  2006-10       Impact factor: 0.635

Review 2.  The role of DXA bone density scans in the diagnosis and treatment of osteoporosis.

Authors:  Glen M Blake; Ignac Fogelman
Journal:  Postgrad Med J       Date:  2007-08       Impact factor: 2.401

Review 3.  Screening and early diagnosis of osteoporosis through X-ray and ultrasound based techniques.

Authors:  Paola Pisani; Maria Daniela Renna; Francesco Conversano; Ernesto Casciaro; Maurizio Muratore; Eugenio Quarta; Marco Di Paola; Sergio Casciaro
Journal:  World J Radiol       Date:  2013-11-28

4.  Device-specific thresholds to diagnose osteoporosis at the proximal femur: an approach to interpreting peripheral bone measurements in clinical practice.

Authors:  J A Clowes; N F A Peel; R Eastell
Journal:  Osteoporos Int       Date:  2006-06-30       Impact factor: 4.507

5.  Reliability and validity of lower extremity computed tomography as a screening tool for osteoporosis.

Authors:  S Y Lee; S-S Kwon; H S Kim; J H Yoo; J Kim; J Y Kim; B C Min; S J Moon; K H Sung
Journal:  Osteoporos Int       Date:  2015-01-16       Impact factor: 4.507

6.  The relationship between the calcaneal bone mineral density and the mental index in post-menopausal females.

Authors:  E Jagelaviciene; A Krasauskiene; R Zalinkevicius; R Kubilius; I Vaitkeviciene
Journal:  Dentomaxillofac Radiol       Date:  2013-02-18       Impact factor: 2.419

7.  Prediction of hip osteoporosis by DXA using a novel pulse-echo ultrasound device.

Authors:  J T Schousboe; O Riekkinen; J Karjalainen
Journal:  Osteoporos Int       Date:  2016-08-04       Impact factor: 4.507

8.  Multi-site bone ultrasound measurements in elderly women with and without previous hip fractures.

Authors:  J P Karjalainen; O Riekkinen; J Töyräs; M Hakulinen; H Kröger; T Rikkonen; K Salovaara; J S Jurvelin
Journal:  Osteoporos Int       Date:  2011-06-09       Impact factor: 4.507

9.  Hip and fragility fracture prediction by 4-item clinical risk score and mobile heel BMD: a women cohort study.

Authors:  Daniel Albertsson; Dan Mellström; Christer Petersson; Hans Thulesius; Robert Eggertsen
Journal:  BMC Musculoskelet Disord       Date:  2010-03-24       Impact factor: 2.362

10.  Femur ultrasound (FemUS)--first clinical results on hip fracture discrimination and estimation of femoral BMD.

Authors:  R Barkmann; S Dencks; P Laugier; F Padilla; K Brixen; J Ryg; A Seekamp; L Mahlke; A Bremer; M Heller; C C Glüer
Journal:  Osteoporos Int       Date:  2009-08-20       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.